Literature DB >> 21195797

Reporting of treatment effects from randomized trials: a plea for multivariable risk ratios.

Rolf H H Groenwold1, Karel G M Moons, Linda M Peelen, Mirjam J Knol, Arno W Hoes.   

Abstract

Clinicians are typically interested in the effects of medical interventions that apply to individual patients. Such individual effects are conditional effects rather than marginal (or population averaged) effects. When considering odds ratios, conditional (adjusted) and marginal (crude) effects may differ, even in a randomized trial with perfectly balanced baseline covariates, due to non-collapsibility of the odds ratio. Using a numerical example, we explained this phenomenon of non-collapsibility of the odds ratio and showed that the difference between conditional and marginal odds ratios depends on the strength of the association between a third (stratifying) variable and the outcome, as well as on the distribution of this stratifying variable in the trial population. Risk ratios are not affected by non-collapsibility and therefore, conditional and marginal risk ratios are the same when adjusting for well balanced baseline covariates in randomized trials. Reports on randomized trials should more often include treatment effects that are expressed as risk ratios rather than odds ratios. When odds ratios are used, adjustment for baseline covariates should be considered, also when these are well-balanced between the treatment groups.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21195797     DOI: 10.1016/j.cct.2010.12.011

Source DB:  PubMed          Journal:  Contemp Clin Trials        ISSN: 1551-7144            Impact factor:   2.226


  8 in total

1.  Covariate adjustment increased power in randomized controlled trials: an example in traumatic brain injury.

Authors:  Elizabeth L Turner; Pablo Perel; Tim Clayton; Phil Edwards; Adrian V Hernández; Ian Roberts; Haleema Shakur; Ewout W Steyerberg
Journal:  J Clin Epidemiol       Date:  2011-12-09       Impact factor: 6.437

2.  Overestimation of risk ratios by odds ratios in trials and cohort studies: alternatives to logistic regression.

Authors:  Mirjam J Knol; Saskia Le Cessie; Ale Algra; Jan P Vandenbroucke; Rolf H H Groenwold
Journal:  CMAJ       Date:  2011-12-12       Impact factor: 8.262

3.  Selection of confounding variables should not be based on observed associations with exposure.

Authors:  Rolf H H Groenwold; Olaf H Klungel; Diederick E Grobbee; Arno W Hoes
Journal:  Eur J Epidemiol       Date:  2011-07-28       Impact factor: 8.082

4.  Social relationship correlates of major depressive disorder and depressive symptoms in Switzerland: nationally representative cross sectional study.

Authors:  Steven D Barger; Nadine Messerli-Bürgy; Jürgen Barth
Journal:  BMC Public Health       Date:  2014-03-24       Impact factor: 3.295

5.  Impact of Modified Transesophageal Echocardiography on Mortality and Stroke after Cardiac Surgery: A Large Cohort Study.

Authors:  Wouter W Jansen Klomp; Carl G M Moons; Arno P Nierich; George J Brandon Bravo Bruinsma; Arnoud W J Van't Hof; Jan G Grandjean; Linda M Peelen
Journal:  Int J Vasc Med       Date:  2017-09-11

6.  Impact of Selection Bias on Estimation of Subsequent Event Risk.

Authors:  Yi-Juan Hu; Amand F Schmidt; Frank Dudbridge; Michael V Holmes; James M Brophy; Vinicius Tragante; Ziyi Li; Peizhou Liao; Arshed A Quyyumi; Raymond O McCubrey; Benjamin D Horne; Aroon D Hingorani; Folkert W Asselbergs; Riyaz S Patel; Qi Long
Journal:  Circ Cardiovasc Genet       Date:  2017-10

7.  Does integrated training in evidence-based medicine (EBM) in the general practice (GP) specialty training improve EBM behaviour in daily clinical practice? A cluster randomised controlled trial.

Authors:  M F Kortekaas; M E L Bartelink; N P A Zuithoff; G J M G van der Heijden; N J de Wit; A W Hoes
Journal:  BMJ Open       Date:  2016-09-13       Impact factor: 2.692

8.  False Appearance of Gene-Environment Interactions in Genetic Association Studies.

Authors:  Yi-Shan Su; Wen-Chung Lee
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.